GuidelinePsychiatry and clinical neurosciences2024
Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders).
Guideline in Psychiatry and clinical neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Thyrotropin levels in first-episode bipolar disorder and their association with clinical phenotypes: systematic review and meta-analysis.Frontiers in endocrinology · 2025Pooled it
- Clinical characteristics of patients presenting with depressive states who are not receiving antidepressants: A multicenter observational study in Japanese psychiatric practice.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Review
- Development of an Essential Information Set for Supporting Life With Bipolar Disorder: A Modified Delphi Study With Patients, Families and Healthcare Professionals.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Consciousness disturbance due to lithium carbonate intoxication developed in a patient with cancer and bipolar affective disorder: A case report and literature review.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Associations Between Depressive Symptoms, Cognitive Impairment, and Work Productivity Loss in Patients With Bipolar Disorder: A 48-Week Longitudinal Analysis.Neuropsychopharmacology reports · 2025Article
- Bipolar disorder.Lancet (London, England) · 2025Review
- Accelerated intermittent theta burst stimulation for pharmacological treatment-resistant bipolar depression: Protocol for double-blind, randomized, sham-controlled trial.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study.BMC psychiatry · 2025Observational
Corrections and comments
- Erratum issued
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Japanese Society of Mood Disorders (JSMD) published treatment guidelines of bipolar disorder in 2011. The present guidelines incorporating new findings were developed to comply to the guidelines of the National Academy of Medicine (NAM) by utilizing systematic reviews and meta-analysis and taking patient and family opinions as well as insights from multiple professional fields into account. They support combination therapy using mood stabilizers and second-generation antipsychotics in many aspects. They also have limitations, including the grouping of mood stabilizers and second-generation antipsychotics when meta-analysis was performed despite their distinct properties, due to the scarcity of drug-specific evidence. Despite the limitations, these guidelines provide clinical decision support for psychiatrists in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.